IRCT20170201032346N5已完成未知
The effect of spiramycin in prevention of toxoplasma gondii infection from mothers with acute toxoplasmosis
Ramsar Campus, Mazandaran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 40 years（—）
- 性别
- Female
入选标准
- •Positive Anti-Toxoplasma gondii IgG and IgM antibodies
- •Signed informed consent
排除标准
- •High positive avidity test
- •Negative Anti-Toxoplasma gondii IgM antibodies
- •Positive screening tests for fetal anomalies
研究者
相似试验
Unknown
4 期
Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus ErythematousLupus Erythematosus, SystemicNCT03042260Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran310
已完成
3 期
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular ToxoplasmosisOcular ToxoplasmosisNCT01449877University of Campinas, Brazil141
招募中
4 期
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisToxoplasmosisNCT00004317National Institute of Allergy and Infectious Diseases (NIAID)600
已完成
不适用
Effect of silymarin in prevention of adverse effects of anti tuberculosis drugsDrug induced hepatitis by anti tuberculosis.Antimycobacterial drugsIRCT138903294209N1ational Institute of tuberculosis and lung disease60
已完成
2 期
The efficacy of anti – toxoplasma drugs in the treatment of schizophrenia , a triple – blind, randomized , placebo-controlled clinical trialSchizophrenia.SchizophreniaIRCT201303287373N4Arak University of Medical Sciences200